Wave Life Sciences to Present at Upcoming Investor Conferences
Wave Life Sciences (Nasdaq: WVE) has announced its participation in two major investor conferences this December. Paul Bolno, MD, MBA, President and CEO, will represent the company at both events. The first appearance will be an analyst-led fireside chat at the 7th Annual Evercore HealthCONx Conference on December 3, 2024, at 3:00 p.m. ET. The following day, December 4, he will participate in a Neuromuscular Disorders panel at the Citi 2024 Global Healthcare Conference at 1:00 p.m. ET. Both presentations will be available via webcast on the company's investor relations website, with replays accessible for a time.
Wave Life Sciences (Nasdaq: WVE) ha annunciato la sua partecipazione a due importanti conferenze per investitori questo dicembre. Paul Bolno, MD, MBA, Presidente e CEO, rappresenterà l'azienda a entrambi gli eventi. La prima apparizione sarà una chiacchierata informale guidata da un analista durante il 7° Annual Evercore HealthCONx Conference il 3 dicembre 2024, alle 15:00 ET. Il giorno seguente, 4 dicembre, parteciperà a un panel sui Disturbi Neuromuscolari al Citi 2024 Global Healthcare Conference alle 13:00 ET. Entrambi gli interventi saranno disponibili tramite webcast sul sito web delle relazioni con gli investitori dell'azienda, con la possibilità di rivederli per un certo periodo.
Wave Life Sciences (Nasdaq: WVE) ha anunciado su participación en dos importantes conferencias para inversores este diciembre. Paul Bolno, MD, MBA, Presidente y CEO, representará a la empresa en ambos eventos. La primera aparición será una charla informal dirigida por un analista en la 7ª Conferencia Anual Evercore HealthCONx el 3 de diciembre de 2024, a las 3:00 p.m. ET. Al día siguiente, 4 de diciembre, participará en un panel sobre Trastornos Neuromusculares en la Citi 2024 Global Healthcare Conference a la 1:00 p.m. ET. Ambas presentaciones serán disponibles a través de un webcast en el sitio web de relaciones con inversores de la empresa, con repeticiones accesibles durante un tiempo.
웨이브 라이프 사이언스 (Nasdaq: WVE)는 이번 12월 두 가지 주요 투자자 컨퍼런스에 참여한다고 발표했습니다. 폴 볼노, MD, MBA, 사장 겸 CEO가 두 행사에서 회사를 대표할 것입니다. 첫 번째는 제7회 에버코어 헬스CONx 컨퍼런스에서 2024년 12월 3일 오후 3시(동부 표준시)에 분석가 주도의 대담입니다. 그 다음 날인 12월 4일에는 Citi 2024 글로벌 헬스케어 컨퍼런스에서 오후 1시(동부 표준시)에 신경근육 장애 패널에 참여할 예정입니다. 두 발표 모두 회사의 투자자 관계 웹사이트를 통해 웹캐스트로 제공되며, 일정 기간 동안 재생 가능합니다.
Wave Life Sciences (Nasdaq: WVE) a annoncé sa participation à deux importantes conférences pour investisseurs ce mois de décembre. Paul Bolno, MD, MBA, Président et CEO, représentera la société lors des deux événements. La première apparition sera une discussion informelle guidée par un analyste lors de la 7ème Conférence Annuelle Evercore HealthCONx le 3 décembre 2024 à 15h00 ET. Le lendemain, le 4 décembre, il participera à un panel sur les troubles neuromusculaires lors de la Citi 2024 Global Healthcare Conference à 13h00 ET. Les deux présentations seront disponibles via un webinaire sur le site internet des relations investisseurs de la société, avec des rediffusions accessibles pendant un certain temps.
Wave Life Sciences (Nasdaq: WVE) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im Dezember bekannt gegeben. Paul Bolno, MD, MBA, Präsident und CEO, wird das Unternehmen bei beiden Veranstaltungen vertreten. Der erste Auftritt wird ein von Analysten geleitetes Kaminplausch-Gespräch auf der 7. jährlichen Evercore HealthCONx-Konferenz am 3. Dezember 2024 um 15:00 Uhr ET sein. Am folgenden Tag, dem 4. Dezember, wird er an einem Panel zu neuromuskulären Erkrankungen auf der Citi 2024 Global Healthcare Conference um 13:00 Uhr ET teilnehmen. Beide Präsentationen werden über einen Webcast auf der Investor-Relations-Website des Unternehmens verfügbar sein, mit Wiederholungen, die für eine bestimmte Zeit zugänglich sind.
- None.
- None.
CAMBRIDGE, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in two upcoming investor conferences in December.
7ᵗʰ Annual Evercore HealthCONx Conference
Date: Tuesday, December 3, 2024
Analyst-led fireside chat: 3:00 p.m. ET
Citi 2024 Global Healthcare Conference
Date: Wednesday, December 4, 2024
“Neuromuscular Disorders” panel: 1:00 p.m. ET
Live webcasts of these presentations can be accessed by visiting “Investor Events” on the Investor Relations section of the Wave Life Sciences website: https://ir.wavelifesciences.com/events-publications/events. A replay of these presentations will be archived and available on the site for a limited time following the event.
About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave’s RNA medicines platform, PRISM®, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Wave’s diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency and Huntington’s disease, as well as a preclinical program in obesity. Driven by the calling to “Reimagine Possible”, Wave is leading the charge toward a world in which human potential is no longer hindered by the burden of disease. Wave is headquartered in Cambridge, MA. For more information on Wave’s science, pipeline and people, please visit www.wavelifesciences.com and follow Wave on X (formerly Twitter) and LinkedIn.
Investor Contact:
Kate Rausch
+1 617-949-4827
krausch@wavelifesci.com
Media Contact:
Alicia Suter
+1 617-949-4817
asuter@wavelifesci.com
FAQ
When is Wave Life Sciences (WVE) presenting at the Evercore HealthCONx Conference in December 2024?
What panel is Wave Life Sciences (WVE) participating in at the Citi 2024 Global Healthcare Conference?
Where can investors watch Wave Life Sciences' (WVE) December 2024 conference presentations?
